Treatment activism, unknown five years ago, has been an important development of the AIDS epidemic. Activist pressure has pushed the government into greatly reducing the time taken to bring experimental treatments to market. For the first time in history, representatives of community-based organizations sit on scientific core committees and panels overseeing AIDS research. This activism must continue. While distrust of the political process and government runs deep among people with AIDS, particularly in communities of color, people with AIDS need to work with the research and drug development establishment so that experimental drugs under development reach communities that need them the most. The Federal government has never made treatment information easy to access. Therefore, activists and advocates need to continue their efforts to provide life-saving and life-extending information in treatment newsletters and fact sheets, community forums, treatment hotlines, and online communication networks.